Choose Site

Newsletter

Blockbuster Biologics Review

2018–2021
Biologics

Blockbuster Biologics Review, produced by our intellectual property lawyers, covers developments in inter partes review (IPR) and patent litigation challenges to blockbuster biologic drugs.

These quarterly reports provide updates on the following topics:

  • The current status of IPR challenges to blockbuster biologics
  • The institution and invalidation rates for IPRs challenging blockbuster biologics
  • The current status of patent litigations implicating blockbuster biologics

We will continue to monitor developments and provide updates regularly.

Read the current issue >>

Past Issues

2020

Issue 10 (September 2020) >>

Issue 9 (April 2020) >>

Issue 8 (February 2020) >>

2019

Issue 7 (November 2019) >>

Issue 6 (July 2019) >>

Issue 5 (April 2019) >>

Issue 4 (January 2019) >>

2018

Issue 3 (October 2018) >>

Issue 2 (July 2018) >>

Issue 1 (April 2018) >>

Additional Resources

News

Thought Leadership